Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 3
2014 5
2015 13
2016 14
2017 12
2018 5
2019 6
2020 3
2021 7
2022 6
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

73 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and Vaccine Shedding After 1 or 2 Doses of rVSVΔG-ZEBOV-GP Ebola Vaccine (ERVEBO®): Results From a Phase 2, Randomized, Placebo-controlled Trial in Children and Adults.
Lee AW, Liu K, Lhomme E, Blie J, McCullough J, Onorato MT, Connor L, Simon JK, Dubey S, VanRheenen S, Deutsch J, Owens A, Morgan A, Welebob C, Hyatt D, Nair S, Hamzé B, Guindo O, Sow SO, Beavogui AH, Leigh B, Samai M, Akoo P, Serry-Bangura A, Fleck S, Secka F, Lowe B, Watson-Jones D, Roy C, Hensley LE, Kieh M, Coller BG; PREVAC Study Team. Lee AW, et al. Clin Infect Dis. 2024 Apr 10;78(4):870-879. doi: 10.1093/cid/ciad693. Clin Infect Dis. 2024. PMID: 37967326 Free PMC article. Clinical Trial.
Revisiting the minimum incubation period of Zaire ebolavirus.
Kofman AD, Haberling DL, Mbuyi G, Martel LD, Whitesell AN, Van Herp M, Makaya G, Corvil S, Abedi AA, Ngoma PM, Mbuyi F, Mossoko M, Koivogui E, Soke N, Gbamou N, Fonjungo PN, Keita L, Keita S, Shoemaker TR, Richards GA, Montgomery JM, Breman JG, Geisbert TW, Choi MJ, Rollin PE. Kofman AD, et al. Among authors: keita s. Lancet Infect Dis. 2023 Oct;23(10):1111-1112. doi: 10.1016/S1473-3099(23)00506-6. Epub 2023 Aug 18. Lancet Infect Dis. 2023. PMID: 37604181 No abstract available.
Quantifying the value of viral genomics when inferring who infected whom in the 2014-16 Ebola virus outbreak in Guinea.
Robert A, Tsui Lok Hei J, Watson CH, Gsell PS, Hall Y, Rambaut A, Longini IM Jr, Sakoba K, Kucharski AJ, Touré A, Danmadji Nadlaou S, Saidou Barry M, Fofana TO, Lansana Kaba I, Sylla L, Diaby ML, Soumah O, Diallo A, Niare A, Diallo A, Eggo RM, Caroll MW, Henao-Restrepo AM, Edmunds WJ, Hué S. Robert A, et al. Among authors: sakoba k. Virus Evol. 2023 Mar 7;9(1):vead007. doi: 10.1093/ve/vead007. eCollection 2023. Virus Evol. 2023. PMID: 36926449 Free PMC article.
Randomized Trial of Vaccines for Zaire Ebola Virus Disease.
PREVAC Study Team; Kieh M, Richert L, Beavogui AH, Grund B, Leigh B, D'Ortenzio E, Doumbia S, Lhomme E, Sow S, Vatrinet R, Roy C, Kennedy SB, Faye S, Lees S, Millimouno NP, Camara AM, Samai M, Deen GF, Doumbia M, Espérou H, Pierson J, Watson-Jones D, Diallo A, Wentworth D, McLean C, Simon J, Wiedemann A, Dighero-Kemp B, Hensley L, Lane HC, Levy Y, Piot P, Greenwood B, Chêne G, Neaton J, Yazdanpanah Y. PREVAC Study Team, et al. N Engl J Med. 2022 Dec 29;387(26):2411-2424. doi: 10.1056/NEJMoa2200072. Epub 2022 Dec 14. N Engl J Med. 2022. PMID: 36516078 Clinical Trial.
Lessons learned for surveillance system strengthening through capacity building and partnership engagement in post-Ebola Guinea, 2015-2019.
Hemingway-Foday JJ, Diallo BI, Compaore S, Bah S, Keita S, Diallo IT, Martel LD, Standley CJ, Bah MB, Bah M, Camara D, Kaba AK, Keita L, Kone M, Reynolds E, Souare O, Stolka KB, Tchwenko S, Wone A, Worrell MC, MacDonald PDM. Hemingway-Foday JJ, et al. Among authors: keita s. Front Public Health. 2022 Aug 11;10:715356. doi: 10.3389/fpubh.2022.715356. eCollection 2022. Front Public Health. 2022. PMID: 36033803 Free PMC article.
Detection of Marburg Virus Disease in Guinea.
Koundouno FR, Kafetzopoulou LE, Faye M, Renevey A, Soropogui B, Ifono K, Nelson EV, Kamano AA, Tolno C, Annibaldis G, Millimono SL, Camara J, Kourouma K, Doré A, Millimouno TE, Tolno FMB, Hinzmann J, Soubrier H, Hinrichs M, Thielebein A, Herzer G, Pahlmann M, Ki-Zerbo GA, Formenty P, Legand A, Wiley MR, Faye O, Diagne MM, Sall AA, Lemey P, Bah A, Günther S, Keita S, Duraffour S, Magassouba N. Koundouno FR, et al. Among authors: keita s. N Engl J Med. 2022 Jun 30;386(26):2528-2530. doi: 10.1056/NEJMc2120183. N Engl J Med. 2022. PMID: 35767445 Free PMC article. No abstract available.
Implementing a DHIS2 Ebola virus disease module during the 2021 Guinea Ebola outbreak.
Eggers C, Martel L, Dismer A, Kallay R, Sayre D, Choi M, Corvil S, Kaba A, Keita B, Diallo L, Balde MM, Bah M, Camara SM, Koivogui E, Montgomery J, Keita S. Eggers C, et al. Among authors: keita s. BMJ Glob Health. 2022 May;7(5):e009240. doi: 10.1136/bmjgh-2022-009240. BMJ Glob Health. 2022. PMID: 35589157 Free PMC article.
Temporal evolution of the humoral antibody response after Ebola virus disease in Guinea: a 60-month observational prospective cohort study.
Diallo MSK, Ayouba A, Keita AK, Thaurignac G, Sow MS, Kpamou C, Barry TA, Msellati P, Etard JF, Peeters M, Ecochard R, Delaporte E, Toure A; PostEbogui Study Group. Diallo MSK, et al. Lancet Microbe. 2021 Dec;2(12):e676-e684. doi: 10.1016/S2666-5247(21)00170-1. Epub 2021 Sep 3. Lancet Microbe. 2021. PMID: 35544108 Free article.
73 results